Remember how the FDA delayed the Coronavirus Vaccine until after the election by requiring the strictest standards ever for a vaccine

A month before the election the FDA changed the rules on approving vaccines. The motivation was that they needed stricter rules this time for approval because people were concerned that this vaccine would be particularly dangerous. Just something to remember:

The most notable guideline to emerge from the FDA’s new advisory stipulates that data from phase 3 studies of any potential COVID-19 vaccine should include a median follow-up duration of at least two months after patient’s receive their final dose.

This guidance ensures that no COVID-19 vaccine is likely to be approved before the US presidential election, which is taking place on 3 November. US president Donald Trump has said a number of times over the last few months that a vaccine for COVID-19 could come before election day ...